Posted by Michael Wonder on 05 Oct 2020
Moderna CEO says COVID-19 vaccine will be ready for FDA submission in late November
5 October 2020 - Company will seek emergency use authorisation for experimental vaccine.
Moderna’s chief executive officer Stéphane Bancel said that he expects Moderna to be ready to submit its COVID-19 vaccine candidate to the US FDA in November.
Bancel revealed the possible timelines for approval and availability of the company’s mRNA-based COVID-19 vaccine candidate at the US Pharma and Biotech Conference hosted by the Financial Times last week.
